Stepwise Intensification of Prandial Insulin Versus Basal-Bolus Insulin Therapy in Patients (Pts) with Type 2 Diabetes Mellitus (T2DM)

被引：0
|
作者：
Raccah, Denis
Haak, Thomas
Huet, Dominique
Monnier, Louis
Penfornis, Alfred
Robertson, Douglas
Labard, Pascale
Soler Ramon, Juan
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A151 / A151
页数：1
相关论文
共 50 条
  • [21] Cost Benefits of Stepwise Addition of Prandial Insulin Aspart Compared to Full Basal-Bolus Therapy
    Saunders, Rhodri
    Lian, Jean
    Valentine, William
    Karolicki, Boris
    DIABETES, 2014, 63 : A306 - A307
  • [22] Individual stepwise intensification of insulin analogue therapy in type 2 diabetes mellitus
    Ametov, A. S.
    Chernikova, N. A.
    DIABETES MELLITUS, 2012, 15 (04): : 89 - 94
  • [23] OPTIMAL REGIMENS OF THE BASAL-BOLUS INSULIN THERAPY IN ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
    Galkina, G. A.
    Voropay, A. A.
    Levkovich, M. A.
    Vorobiov, S. V.
    Komkova, M. V.
    Morozova, N. V.
    BYULLETEN SIBIRSKOY MEDITSINY, 2015, 14 (05): : 15 - U223
  • [24] Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial
    Rosenstock, Julio
    Guerci, Bruno
    Hanefeld, Markolf
    Gentile, Sandro
    Aronson, Ronnie
    Tinahones, Francisco J.
    Roy-Duval, Christine
    Souhami, Elisabeth
    Wardecki, Marek
    Ye, Jenny
    Perfetti, Riccardo
    Heller, Simon
    DIABETES CARE, 2016, 39 (08) : 1318 - 1328
  • [25] Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naive Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia
    Shafie, Asrul Akmal
    Ng, Chin Hui
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 333 - 343
  • [26] Proportion and characteristics of patients with type 2 diabetes initiating basal insulin therapy with a basal-bolus regimen in China
    Zhang, Puhong
    Zhang, Heng
    Zhu, Dongshan
    Li, Xian
    Ji, Jiachao
    Zhao, Fang
    Lu, Juming
    Jia, Weiping
    Ji, Linong
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [27] An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK
    Palmer, Andrew J.
    Valentine, William J.
    Ray, Joshua A.
    Foos, Volker
    Lurati, Francesco
    Smith, Inger
    Lammert, Morten
    Roze, Stephane
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (04) : 895 - 901
  • [28] Near-Normoglycemia, with Meaningful Discontinuations of Prandial Insulin, by Adding Weekly Albiglutide (Albi) to Uncontrolled Basal/Bolus Insulin-Treated Type 2 Diabetes (T2DM)
    Rosenstock, Julio
    Nino, Antonio J.
    Soffer, Joseph
    Mallory, Jason M.
    Erskine, Lois M.
    Acusta, Andre
    Dole, Jo F.
    Carr, Molly
    Home, Philip
    DIABETES, 2018, 67
  • [29] Insulin detemir and insulin aspart:: a promising basal-bolus regimen for type 2 diabetes
    Raslová, K
    Bogoev, M
    Raz, I
    Leth, G
    Gall, MA
    Hancu, N
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 66 (02) : 193 - 201
  • [30] Continuous Glucose Monitoring in hospitalized Patients with Type 2 Diabetes during Basal-Bolus Insulin Therapy
    Schaupp, Lukas
    Neubauer, Katharina
    Mader, Julia
    Augustin, Thomas
    Spat, Stephan
    Hoell, Bernhard
    Beck, Peter
    Plank, Johannes
    Pieber, Thomas
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 : S15 - S15
12345